MERIDIAN BIOSCIENCE INC (VIVO) Stock Analyst Earnings Estimates
NASDAQ:VIVO - Nasdaq - US5895841014 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 253.7M 26.22% | 317.896M 25.30% | 333.018M 4.76% | 294.11M -11.68% | |
| EBITDA YoY % growth | 81.56M 66.93% | 117.111M 43.59% | 92.111M -21.35% | N/A | |
| EBIT YoY % growth | 68M 74.81% | 101.825M 49.74% | 75.6M -25.75% | 46.971M -37.87% | |
| Operating Margin | 26.80% | 32.03% | 22.70% | 15.97% | |
| EPS YoY % growth | 0.98 44.12% | 1.68 71.43% | 1.38 -17.86% | 0.84 -39.02% |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.21 -40.26% | 0.22 -66.00% | 0.20 24.31% | 0.21 2.00% |
| Revenue Q2Q % growth | 73.757M -16.51% | 74.309M -33.19% | 71.082M 4.89% | 74.961M 14.14% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 8.69M -57.74% | 11.016M -70.00% | 12.76M 36.35% | 14.504M 61.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 0.21 -12.50% | 0.15 | 0.06 | 37.25% |
| Q3 2022 Q2Q % growth | 0.16 -27.27% | 0.16 | 0.00 | -1.96% |
| Q2 2022 Q2Q % growth | 0.66 15.79% | 0.48 | 0.18 | 36.22% |
| Q1 2022 Q2Q % growth | 0.35 -46.15% | 0.26 | 0.09 | 37.25% |
| Q4 2021 Q2Q % growth | 0.24 140.00% | 0.21 | 0.03 | 14.78% |
| Q3 2021 Q2Q % growth | 0.22 -60.00% | 0.31 | -0.09 | -29.67% |
| Q2 2021 Q2Q % growth | 0.57 147.83% | 0.49 | 0.08 | 17.23% |
| Q1 2021 Q2Q % growth | 0.65 550.00% | 0.43 | 0.22 | 52.94% |
| Q4 2020 Q2Q % growth | 0.10 -23.08% | 0.14 | -0.04 | -28.27% |
| Q3 2020 Q2Q % growth | 0.55 243.75% | 0.24 | 0.31 | 131.10% |
| Q2 2020 Q2Q % growth | 0.23 21.05% | 0.08 | 0.15 | 181.86% |
| Q1 2020 Q2Q % growth | 0.10 -50.00% | 0.07 | 0.03 | 50.83% |
| Q4 2019 Q2Q % growth | 0.13 | 0.09 | 0.04 | 37.78% |
| Q3 2019 Q2Q % growth | 0.16 | 0.09 | 0.07 | 69.58% |
| Q2 2019 Q2Q % growth | 0.19 | 0.17 | 0.02 | 14.63% |
| Q1 2019 Q2Q % growth | 0.20 | 0.18 | 0.02 | 13.67% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 65.675M -13.82% | 68.782M | -3.107M | -4.52% |
| Q3 2022 Q2Q % growth | 67.771M 6.71% | 68.152M | -381K | -0.56% |
| Q2 2022 Q2Q % growth | 111.231M 30.45% | 101.53M | 9.701M | 9.55% |
| Q1 2022 Q2Q % growth | 88.341M -4.93% | 71.699M | 16.642M | 23.21% |
| Q4 2021 Q2Q % growth | 76.204M 18.79% | 69.765M | 6.439M | 9.23% |
| Q3 2021 Q2Q % growth | 63.511M -25.10% | 78.763M | -15.252M | -19.36% |
| Q2 2021 Q2Q % growth | 85.264M 48.80% | 86.171M | -907K | -1.05% |
| Q1 2021 Q2Q % growth | 92.92M 95.95% | 85.568M | 7.352M | 8.59% |
| Q4 2020 Q2Q % growth | 64.15M 26.16% | 60.832M | 3.318M | 5.45% |
| Q3 2020 Q2Q % growth | 84.8M 75.06% | 67.361M | 17.439M | 25.89% |
| Q2 2020 Q2Q % growth | 57.3M 14.03% | 50.247M | 7.053M | 14.04% |
| Q1 2020 Q2Q % growth | 47.42M -7.89% | 49.67M | -2.25M | -4.53% |
| Q4 2019 Q2Q % growth | 50.85M | 51.603M | -753K | -1.46% |
| Q3 2019 Q2Q % growth | 48.44M | 50.806M | -2.366M | -4.66% |
| Q2 2019 Q2Q % growth | 50.25M | 52.777M | -2.527M | -4.79% |
| Q1 2019 Q2Q % growth | 51.48M | 54.163M | -2.683M | -4.95% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -4.62% |
| Revenue | N/A | N/A | 0% | -5.21% |